Introduction
Mitral stenosis is almost invariably the result of rheumatic fever, which is becoming less frequent in industrialized countries. However, mitral stenosis still accounts for more than 10% of valvular heart diseases in Europe, in particular because of immigrant populations [1] . Rheumatic heart disease remains a public health problem in developing countries mainly due to the lack of medical prophylaxis and poor living conditions [2] . However, despite marked differences in the prevalence of rheumatic heart disease across the world, little is known about geographic variations in the characteristics of patients with severe mitral stenosis and their potential consequences on the immediate results of PMC.
Since its introduction in the early 1980s, PMC has had a significant impact on the treatment of mitral stenosis [3] . The successful results obtained with this technique, as assessed by observational and randomized series, explain why PMC has replaced surgical commissurotomy in the majority of cases [4] [5] [6] .
The aim of this study was to test the hypothesis that differences in the epidemiology of rheumatic fever may influence the presentation of patients with mitral stenosis and the results of PMC. To address this issue, we analysed patient characteristics and the immediate results of PMC in seven different centres located across the five continents to compare the two Western with the five non-Western countries.
Materials and methods

Study population
At the end of 2005, we collected the characteristics of the last 50 consecutive patients who underwent PMC in Boston (USA), Maputo (Mozambique), Monastir (Tunisia), Papeete (French Polynesia), Paris (France), Ho Chi Minh City (Viet Nam) and São Paulo (Brazil). The choice of centres ensured a wide range of geographical origins. All patients presented a mitral valve area of less than 1.5 cm 2 and were at least in NYHA functional class II. Contraindications to the procedure were calcification of both commissures, left atrial thrombus, mitral regurgitation grade greater than 2/4 and the coexistence of significant aortic valve disease [6] .
Measurements and procedures
Two-dimensional transthoracic and transoesophageal echocardiographic examinations were performed in the same laboratory for each group by experienced operators on the day preceding and 24 to 48 hours after the procedure.
All operators used the same predefined methods to assess the severity of mitral stenosis, regurgitation and valve anatomy before, during and after the procedure. The reference measurement for valve area was planimetry by two-dimensional echocardiography. In the rare cases where planimetry was not feasible, the Doppler pressure half-time method was used instead. Mean mitral gradient was assessed by continuous-wave Doppler. Mitral regurgitation was quantified in four grades using colour Doppler. Systolic pulmonary artery pressure was derived from the maximum gradient between the right ventricle and atrium using continuouswave Doppler. Morphologic evaluation of the valve was done using the Wilkins score [7] . Balloon commissurotomy was performed by experienced operators, using the Inoue technique in 315 (90.0%) cases, a double-balloon (9.7%) in 34 cases and a metallic commissurotome in one (0.3%) case. With the Inoue technique, balloon size was chosen according to the patient height and the procedure used stepwise inflations under echocardiographic guidance. Criteria for ending the procedure were complete opening of at least one commissure with a valve area greater or equal to 1.5 cm 2 , or greater or equal to 1.0 cm 2 /m 2 of BSA, or the appearance or increase of regurgitation greater than 1/4 [6] .
Good immediate results were defined as valve area greater or equal to 1.5 cm 2 , or greater or equal to 1.0 cm 2 /m 2 BSA without mitral regurgitation greater than 2/4. Complications analysed were in-hospital death, mitral regurgitation greater than 2/4, cardiac tamponade and the need for surgery within the first month. 
Statistical analysis
Results
The mean age of the 350 patients was 41 ± 17 years (range: 11-89) and 283 (81%) were women. Seventeen patients (5%) were aged less than 18 years; all of these patients were treated in non-Western countries. Fifty-five patients (16%) had undergone at least one procedure of commissurotomy previously, which was, either singly or in combination: PMC (n = 36); open-heart commissurotomy (n = 15); and closedheart commissurotomy (n = 7).
Comparisons between the five non-Western and the two Western countries are reported in Tables 1 and 2 . Candidates for PMC from non-Western nations were younger, in a lower NYHA class and had less frequent atrial fibrillation than those from Western countries. This was in contrast with a more severe valvular disease, as shown consistently by a smaller indexed mitral valve area, higher mean mitral gradient and higher systolic artery pulmonary pressure. There were no significant differences concerning overall mitral valve anatomy, as assessed by the Wilkins score. Good immediate results were observed in 225 patients (90%) from non-Western centres and in 88 (88%) from Western centres (p = 0.58). No significant differences were found regarding complication rates between non-Western and Western countries.
Baseline characteristics and immediate results of the 350 patients in the seven centres are detailed in Tables 3 and 4 . Most patient characteristics differed significantly between the seven centres. There were no significant differences in the frequency of complications from PMC. The difference between the frequency of good immediate results from PMC was of borderline significance (p = 0.05).
Discussion
This series is the first enabling the contemporary spectrum of mitral stenosis to be assessed worldwide. Although it is admitted that the presentation of rheumatic heart disease varies across countries, differences in patients' characteristics and their impact on the results of interventions have not been investigated using a homogeneous approach. Our study shows that mitral stenosis is more severe and occurs in younger patients in areas where rheumatic heart disease is 0.57 ± 0.14 0.62 ± 0.14 0.006 still common. Despite these differences, PMC is an effective treatment of mitral stenosis worldwide. According to the latest World Health Organization report [8] , rheumatic heart disease remains a major cause of mortality in developing countries, with more than 230,000 annual directly attributable deaths and a high level of morbidity, with at least 15 million estimated cases of rheumatic heart disease [8, 9] . In addition, the prevalence of rheumatic fever is likely to be underestimated from clinical findings, as shown by the use of systematic echocardiographic examinations [10] . The younger age found among the non-Western population is one of the most significant indications that rheumatic heart disease is more severe in areas where rare penicillin use and living conditions promote streptococcus transmission. More frequent and/or more severe acute rheumatic fever attacks, resulting in an exaggerated immune response to specific bacterial epitopes in a susceptible host, may explain the earlier and more severe form of the disease. Conversely, the decrease in the incidence of rheumatic fever in industrialized countries resulted not only in a decrease in the prevalence of rheumatic heart disease but also in an occurrence at an older age. The comparison between series of surgical commissurotomy performed in the 1950s and 1960s in the USA and in Europe and recent series of PMC shows an increase in the mean age of patient candidates for surgical or percutaneous mitral commissurotomy [11, 12] . The only characteristic that did not differ between the groups was the constant female predominance, which is well-known in mitral stenosis but not explained clearly. This may raise again the hypothesis of a genetic predisposition or susceptibility to rheumatic fever [8, 13] .
In our study, patients from non-Western countries had more severe mitral stenosis. Although the difference was of smaller magnitude with indexed rather than absolute valve area, other indices of severity (mean mitral gradient and systolic pulmonary artery pressure) were consistently higher in patients from non-Western countries. Although the degree of mitral stenosis and its haemodynamic consequences were more severe in patients of non-Western origin, they presented with lower NYHA class, which may be related in part to the younger age and the lower prevalence of atrial fibrillation in patients from non-Western countries [14] . However, it is also necessary to take into account the subjectivity of the assessment of the severity of dyspnoea in the absence of standardized evaluation at exercise.
Although mitral stenosis is the consequence of rheumatic fever, anatomical lesions may differ according to the geographic origin. In particular, valve calcification is (8) 5 (10) 9 (18) 13 (26) 12 (24) 0 12 (24) 0.001
Previous embolism 10 (20) 4 (8) 5 (10) 3 (6) 10 (20) 7 (14) 0 0.01 Pregnancy 1 (2) 1 (2) 7 (14) 3 (6) 1 (2) 2 (4) 3 (6) 2 (4) 1 (2) 2 (4) 0 2 (4) 0.77
Good immediate results
(86)
39 (78) 46 (92) 48 (96) 45 (90) 48 (96) 44 (88) 0.05 encountered more frequently in old patients from Western countries [14] . The absence of difference in the Wilkins score between Western and non-Western countries in our study might be explained by the fact that more frequent calcification in Western countries may be compensated for by more severe impairment of subvalvular apparatus in non-Western countries. However, several reports emphasize that significant subvalvular deformity cannot be used as the unique predictive factor of immediate results of PMC [15] [16] [17] . There were no significant differences in complication rates after PMC between the patients from non-Western and Western countries. Severe mitral regurgitation results frequently from non-commissural leaflet tearing; it is the most frequent complication of the procedure and is not related closely to patient characteristics. Other complication rates are known to be related mainly to the experience of operators [18] . The absence of difference in complication rates may be explained by the fact that all procedures in the seven centres were performed by experienced operators, thereby limiting bias inherent to the learning curve.
Despite marked differences in patient characteristics, there were no significant differences in the success rate of PMC between Western and non-Western countries. This illustrates that the prediction of immediate results of PMC is multifactorial and does not rely solely on valve anatomy but also on clinical factors, age and consequences of valve disease [15] [16] [17] 19] . Pulmonary artery hypertension, small mitral valve area and high gradient have been described as predictors of poor immediate results of the procedure and were encountered more frequently in non-Western countries [20] . However, this may be compensated for by the older age and the more frequent atrial fibrillation in Western countries, which have also been identified as predictive of poor results of PMC [15] .
PMC seems to give a higher increase in valve area in patients from non-Western countries. This trend is found in the literature when comparing the results of large published series from Western [17, 21] and non-Western countries [22] [23] [24] .
The composite endpoint of good immediate results used in our study takes into account the two main phenomena that may require mitral surgery, that is insufficient valve opening and the occurrence of severe mitral regurgitation. A mitral valve greater or equal to 1.5 cm 2 generally provides normal haemodynamic conditions and leads to a persistent functional improvement. This threshold has therefore been used in most studies. We also considered an indexed valve area greater or equal to 1.0 cm 2 /m 2 BSA to be a good result. The rationale was to avoid considering patients of small body size, who had a post-PMC valve area less than 1.5 cm 2 but greater or equal to 1.0 cm 2 /m 2 BSA, as having a poor immediate result from PMC. The difference in body size of patients from non-Western -particularly Asian -countries and the proportion of young patients (4.9% of all patients and 6.8% of the non-Western population were aged less than 18 years) justify the use of an indexed valve area, even if no indexed threshold is established for mitral stenosis.
This study shows that a number of patients with non-ideal anatomical conditions derived benefit from PMC as the initial treatment. Surgery was used in case of failure of PMC rather than as a first-line treatment in these cases [18] . Moreover, a number of patients from non-Western countries presented with high pulmonary pressure and were therefore at high risk for surgery, which can be a further incentive for the use of a percutaneous procedure as a first-line treatment.
Study limitations
Differences in healthcare systems between countries may account for a referral bias. However, the younger age of patients from non-Western countries shows that the higher severity of mitral stenosis cannot be explained by late referral.
Certain patients undergoing PMC in Western areas are immigrants from non-Western countries. Therefore, classifying patients in terms of their ethnic origin rather than their country of residence would probably lead to even more marked differences.
Different components of the Wilkins score (leaflet mobility, valvular thickening, subvalvular thickening and valvular calcification) were not analysed in this series. Thus, it was not possible to compare in detail the anatomical impairment of the different components of the mitral apparatus.
Nevertheless, the strength of this series was the inclusion of consecutive patients from a wide range of centres during the same period, using the Inoue technique in 90% of cases. Thus, our results are likely to reflect the contemporary presentation of patient candidates for PMC. Larger single-centre series have been reported in numerous countries. However, they covered long time periods during which changes occurred in patient selection and technique. This heterogeneity precludes valid comparisons being made between different series to assess the relationship between the differences in patient characteristics and the results of PMC.
Conclusion
Compared with patients from Western countries, candidates for PMC from non-Western countries are younger, have more severe valve stenosis and pulmonary hypertension, but a lower frequency of atrial fibrillation and previous embolism. Despite marked differences, PMC achieves good immediate results in a similarly high proportion of patients from different geographical areas, further illustrating the wide applicability of this technique.
